The magnitude of the AZD7648 and olaparib combination treatment response in the FaDu ATM KO xenografts in vivo (where tumour volumes started to regress after 10 days of treatment) was more striking than the combination in vitro, suggesting that the length of treatment and the accumulation of DNA damage is an important factor in achieving significant anti-tumour effects. This evidence concerns the gene ATM and neoplasm.